Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01505
|
|||||
Drug Name |
Dolastatin 10
|
|||||
Synonyms |
Dolastatin 10; Dolastatin-10; Dolostatin 10; UNII-EI946JT51X; CCRIS 7310; CHEBI:67357; NSC 376128; EI946JT51X; L-Valinamide, N,N-dimethyl-L-valyl-N-[(1S,2R)-2-methoxy-4-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[[(1S)-2-phenyl-1-(2-thiazolyl)ethyl]amino]propyl]-1-pyrrolidinyl]-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-
|
|||||
Indication | Leukemia [ICD11: 2A60-2B33] | Phase 2 | [1] | |||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C42H68N6O6S
|
|||||
Canonical SMILES |
CCC(C)C(C(CC(=O)N1CCCC1C(C(C)C(=O)NC(CC2=CC=CC=C2)C3=NC=CS3)OC)OC)N(C)C(=O)C(C(C)C)NC(=O)C(C(C)C)N(C)C
|
|||||
InChI |
InChI=1S/C42H68N6O6S/c1-13-28(6)37(47(10)42(52)35(26(2)3)45-40(51)36(27(4)5)46(8)9)33(53-11)25-34(49)48-22-17-20-32(48)38(54-12)29(7)39(50)44-31(41-43-21-23-55-41)24-30-18-15-14-16-19-30/h14-16,18-19,21,23,26-29,31-33,35-38H,13,17,20,22,24-25H2,1-12H3,(H,44,50)(H,45,51)/t28-,29+,31-,32-,33+,35-,36-,37-,38+/m0/s1
|
|||||
InChIKey |
OFDNQWIFNXBECV-VFSYNPLYSA-N
|
|||||
CAS Number |
CAS 110417-88-4
|
|||||
Pharmaceutical Properties | Molecular Weight | 785.1 | Topological Polar Surface Area | 162 | ||
Heavy Atom Count | 55 | Rotatable Bond Count | 21 | |||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 9 | |||
XLogP |
5.8
|
|||||
PubChem CID | ||||||
ChEBI ID |
CHEBI:67357
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
References | ||||||
1 | ClinicalTrials.gov (NCT00005579) Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia | |||||
2 | Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity. J Biol Chem. 1996 Feb 9;271(6):3163-71. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.